• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-18

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit enables high-resolution separation of low-molecular-weight proteins and peptides (1–10 kDa) not well resolved by conventional Tris-glycine SDS-PAGE. This kit is intended for analytical research workflows and is not suitable for diagnostic or clinical applications.

• KX2-391 Dihydrochloride: Dual Mechanism Src and Tubulin Inhi

  2026-07-17

  KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) is a clinically validated small molecule with dual inhibition of Src kinase and tubulin polymerization. It exhibits potent anticancer, antiviral, and neurotoxin-inhibitory actions, with well-characterized in vitro and in vivo parameters. This article details its mechanisms, protocol recommendations, and key evidence for biomedical research.

• Structural Flexibility of Cyclosporin Variants Determines MP

  2026-07-17

  This study rigorously compares cyclosporin B–E variants and reveals that only congeners with flexible peptide backbones—such as Cyclosporin A—can inhibit mitochondrial permeability transition pore (MPTP) opening. These findings clarify the molecular prerequisites for cyclosporin-mediated mitochondrial regulation and inform the rational design of immunosuppressive and mitochondrial-targeted peptides.

• Ibotenic Acid as an NMDA Receptor Agonist: Protocols & Insig

  2026-07-16

  Ibotenic acid is the neuroscience research tool of choice for robust animal models of neurodegenerative disorders, enabling precise glutamatergic signaling modulation. This article details optimized workflows, troubleshooting strategies, and novel insights from recent in vivo studies—empowering researchers to fully leverage APExBIO’s high-purity ibotenic acid for advanced experimental applications.

• Metoprolol Tartrate: Precision β1-Adrenergic Blockade in Res

  2026-07-16

  Metoprolol Tartrate stands apart as a selective β1-adrenergic blocking agent, enabling nuanced cardiovascular and hematopoietic research without the confounding off-target effects of nonselective β-blockers. Its robust solubility, high purity, and proven experimental resilience make it the go-to compound for reproducible β1 signaling studies.

• HyperFluor™ 488 Goat Anti-Rabbit IgG Antibody: Technical Gui

  2026-07-15

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides researchers with a reliable, affinity-purified fluorescent secondary antibody for sensitive detection of rabbit primary antibodies in immunofluorescence, flow cytometry, and microscopy. It should not be used for non-rabbit primary antibodies or in workflows incompatible with sodium azide or fluorescence-based detection.

• Targeting Glutamine Metabolism in HSCs to Alleviate Liver Fi

  2026-07-15

  This study reveals that glutamine metabolism is essential for the activation and proliferation of hepatic stellate cells (HSCs) in liver fibrosis. By demonstrating that SIRT4-mediated regulation of glutamate dehydrogenase (GDH) suppresses fibrogenesis, the research identifies new metabolic intervention points for antifibrotic therapy.

• FAISL lncRNA Blocks Calpain-2 FAK Cleavage in TNBC Progressi

  2026-07-14

  The reference study uncovers how the long non-coding RNA FAISL promotes triple negative breast cancer (TNBC) progression by inhibiting Calpain-2-mediated proteolysis of focal adhesion kinase (FAK), thereby enhancing FAK stability and metastatic potential. These findings reveal a previously unknown regulatory axis in TNBC and suggest FAISL as a potential target for future therapeutic strategies.

• KX2-391 dihydrochloride (SKU A3535): Reliable Dual-Mechanism

  2026-07-14

  This article addresses real-world experimental challenges in cell viability and cytotoxicity assays, demonstrating how KX2-391 dihydrochloride (SKU A3535) delivers reproducible outcomes across oncology and virology workflows. Integrating quantitative data, scenario-driven Q&A, and best-practice recommendations, it guides researchers in leveraging this dual Src kinase and tubulin inhibitor for rigorous and translationally relevant results.

• Tumor-Targeted PAD4 Inhibition via m-PBA: Mechanistic Advanc

  2026-07-13

  The referenced study introduces a meta-phenylboronic acid (m-PBA) modified PAD4 inhibitor, Compound 5i TFA, which achieves selective tumor targeting through sialic acid-mediated uptake. By specifically inhibiting the PAD4-H3cit-NETs pathway, this approach demonstrates significant antitumor efficacy and immune modulation with minimal toxicity, guiding new strategies in cancer research.

• Spirocyclic POM Analogues Target MmpL3 in Drug-Resistant TB

  2026-07-13

  This study presents the development and biological evaluation of spirocyclic phenyl oxazole methyl (POM) analogues as potent inhibitors of MmpL3, a crucial transporter in Mycobacterium tuberculosis. With sub-micromolar efficacy against both drug-susceptible and resistant TB strains, these compounds offer a promising platform for next-generation anti-tubercular drug discovery.

• Viperin Inhibits Coronavirus Replication by Targeting nsp8

  2026-07-12

  This study reveals that viperin, an interferon-induced enzyme, restricts coronavirus replication by binding to viral non-structural protein 8 (nsp8), thereby disrupting replication-transcription complex assembly and reducing RNA polymerase activity. The work highlights a conserved antiviral mechanism, with implications for developing broad-spectrum RNA virus replication inhibitors.

• Functional Genomic Screens Uncover Drug-Induced Cell Death M

  2026-07-10

  Honeywell et al. introduce MEDUSA, a simulation-assisted framework that distinguishes growth and death contributions in functional genomic screens, enabling precise identification of genes regulating drug-induced lethality. This approach reveals shifts in cell death modalities, providing actionable insights for cancer research and drug mechanism studies.

• Adenosine Triphosphate (ATP): Biological Role and Research U

  2026-07-09

  Adenosine triphosphate (ATP) serves as the universal energy carrier in cellular metabolism and as an extracellular signaling molecule. Recent studies have clarified ATP’s regulatory impact on mitochondrial pathways, notably through modulation of the TCA cycle. High-purity ATP from APExBIO enables reproducible metabolic and signaling research.

• Marein Restores Chemosensitivity by Inhibiting ABCG2 in Canc

  2026-07-09

  A recent study demonstrates that marein, a flavonoid from Coreopsis tinctoria, acts as a selective competitive inhibitor of the ABCG2 transporter, thereby reversing multidrug resistance and enhancing the efficacy of chemotherapeutic agents in resistant cancer cells. This discovery highlights a new avenue for overcoming ABC transporter-mediated drug resistance in oncology.

8063 records 5/538 page Previous Next 12345 下5页 Last page